Hospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2024

  1. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

    Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029

2023

  1. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 503-510

  2. Sex, Temporary Mechanical Circulatory Support, and Heart Transplantation: Insights From a Multi-Institutional Spanish Registry

    JACC: Heart Failure

  3. Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 4, pp. 488-502

  4. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

    Revista Espanola de Cardiologia

2022

  1. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 559-567

2021

  1. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

2020

  1. Robotic thoracic surgery: What’s our direction?

    Revista de Patologia Respiratoria

2019

  1. Diagnostic yield of the implantable loop recorder in octogenarians

    European Geriatric Medicine, Vol. 10, Núm. 1, pp. 129-133

  2. Differences in scar lesion formation between radiofrequency and cryoballoon in atrial fibrillation ablation: A comparison study using ultra-high-density mapping

    Europace, Vol. 21, Núm. 2, pp. 250-258

  3. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

    BMC neurology, Vol. 19, Núm. 1, pp. 167

  4. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients

    Journal of Critical Care, Vol. 51, pp. 117-121

2018

  1. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2017

  1. Perioperative hemoglobin area under the curve is an independent predictor of renal failure after cardiac surgery. Results from a Spanish multicenter retrospective cohort study

    PLoS ONE, Vol. 12, Núm. 2

2016

  1. Evaluación comparativa de cuatro puntuaciones de riesgo para predecir la mortalidad de pacientes con desfibrilador automático implantable en prevención primaria

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1033-1041

2015

  1. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction

    BMC Neurology, Vol. 15, Núm. 1

2014

  1. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury

    PLoS ONE, Vol. 9, Núm. 4

  2. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis

    Critical Care, Vol. 17, Núm. 3

2011

  1. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis

    Critical Care, Vol. 15, Núm. 2